Carbon monoxide poisoning and its effect on QTc prolongation | Canada Hyperbarics Skip to main content
Case Report J Cardiol Cases 2020

Carbon monoxide poisoning and its effect on QTc prolongation

Olatunde O, Raj V, Tambe V, Szombathy T — J Cardiol Cases, 2020

Tier 2, Indexed

Automatically imported from PubMed based on relevance criteria.

Summary

What Researchers Did

Researchers presented the case of a 69-year-old man who experienced a syncopal episode due to carbon monoxide poisoning.

What They Found

Upon admission, the patient's carboxyhemoglobin level was 10.5%, and his electrocardiogram showed a QTc interval of 622 msec. After treatment with hyperbaric oxygen, his QTc improved to 490 msec and carboxyhemoglobin decreased to 1.8% within 15 hours. This suggests a direct link between acute carbon monoxide poisoning and QTc prolongation, with resolution observed after hyperbaric oxygen therapy.

What This Means for Canadian Patients

Carbon monoxide poisoning is a serious condition that can directly affect the heart, causing dangerous rhythm abnormalities like QTc prolongation. For Canadian patients experiencing carbon monoxide poisoning, hyperbaric oxygen therapy is a recognized treatment that may help reduce the levels of carbon monoxide in the body and improve heart function.

Canadian Relevance

This study was not conducted by Canadian authors or in Canada. However, carbon monoxide poisoning is a Health Canada-recognised indication for hyperbaric oxygen therapy.

Study Limitations

As a single case report, the findings of this study cannot be broadly applied to all patients with carbon monoxide poisoning.

Was this summary helpful?

Study Details

Study Type Case Report
Category Carbon Monoxide Poisoning
Source Pubmed
PubMed ID 32636963
Year Published 2020
Journal J Cardiol Cases

Cite This Study

Share

Find a Canadian Clinic Treating Carbon Monoxide Poisoning

Browse verified hyperbaric facilities across Canada.

View Canadian Facilities

Disclaimer: This study summary is provided for informational and educational purposes only. It does not constitute medical advice. The information presented reflects the findings of the original research authors and may not represent the views of Canada Hyperbarics. Always consult a qualified healthcare professional before making treatment decisions.